{
  "docId": "019dd923-622c-750b-8b9a-40e2965928db",
  "docSlug": "e5bffbaac707",
  "documentTitle": "TransMedics (TMDX)",
  "authorId": "58_Scorpion_Capital",
  "authorName": "Scorpion Capital",
  "documentKindSlug": "research-note",
  "documentKindLabel": "Research note",
  "sourceTypeSlug": "short_seller",
  "sourceTypeLabel": "Short seller",
  "presentationDate": "2025-01-10 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.3333334,
  "pageNumber": 298,
  "pageCount": 342,
  "prevPage": 297,
  "nextPage": 299,
  "slideType": "villain_critique",
  "function": "expose_contradiction",
  "density": "dense",
  "nDataPoints": 0,
  "notes": "The slide uses a Q&A transcript format to highlight negative expert sentiment.",
  "elementsJson": [
    "paragraph",
    "quote_block",
    "footnote"
  ],
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019dd923-622c-750b-8b9a-40e2965928db/298",
  "deckHref": "/decks/019dd923-622c-750b-8b9a-40e2965928db",
  "deckJsonHref": "/decks/019dd923-622c-750b-8b9a-40e2965928db.json",
  "deckAnchorHref": "/decks/019dd923-622c-750b-8b9a-40e2965928db#slide-298",
  "components": [
    {
      "bbox": null,
      "kind": "callout",
      "text": "Vanderbilt indicated that TransMedics “absolutely” has no value proposition, with an exodus from the device among the top centers and those who participated in its trials",
      "attrs": null,
      "subkind": null,
      "toolName": "Visual emphasis",
      "toolSlug": "visual-emphasis",
      "confidence": null,
      "componentId": "019dd953-5374-767b-b3bc-6d76e040d2a0",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.45,
        "w": 0.86,
        "x": 0.07,
        "y": 0.48
      },
      "kind": "paragraph",
      "text": "Q: “I would expect that 80% to 90% of the volume has to be the high-volume major centers of excellence, no?”\nA: “They enrolled some of the highest-volume transplant centers in their clinical trial and these were the main ones that were using them until the last couple of years where amongst our group of folks that we talk to across the country who are other high-volume transplant centers as well, there’s been a steady decrease in utilization of TransMedics.”\nQ: “So, you talked to other transplant centers, heart transplant centers, and they don’t use it for the same reasons you do?”\nA: “It’s gotten to the point that the folks that we speak with typically resort to it if there are issues with not having bandwidth, etc. But because so many centers are actively involved in research, whether it’s Paragonix or XVIVO, whatever it may be, or these other competing coolers that have really come out over the last couple of years, there’s less of an incentive to use the OCS for long-distance hearts because we can just use these instead. So, it’s really coming to do I have a certain bandwidth?”\nQ: “So, you can just use what instead?”\nA: “Coolers, these things that keep the heart at a different temperature than the typical preservation method.”\nQ: “So, you’re saying really has no value proposition.”\nA: “Absolutely. Its usage steadily has been declining amongst the high-volume heart transplant centers, and I don’t know how many of the low-volume ones are using them.” -Transplant cardiologist at one of the top centers in the US/world",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "a8423675-9fc5-474e-a708-52d4b3b87bf7",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.86,
        "x": 0.07,
        "y": 0.45
      },
      "kind": "paragraph",
      "text": "No value proposition; usage has tanked in heart among high volume centers",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "bc6555d0-3b63-4cc6-b33b-4dfcd60c472a",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": null,
      "kind": "quote",
      "text": "“They enrolled some of the highest-volume transplant centers in their clinical trial and these were the main ones that were using them until the last couple of years where amongst our group of folks that we talk to across the country who are other high-volume transplant centers as well, there’s been a steady decrease in utilization of TransMedics.” — Transplant cardiologist at one of the top centers in the US/world",
      "attrs": null,
      "subkind": null,
      "toolName": "Authority citation",
      "toolSlug": "authority-citation",
      "confidence": null,
      "componentId": "019dd953-5374-767b-b3bc-70b5b9e837f9",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.02,
        "w": 0.3,
        "x": 0.07,
        "y": 0.95
      },
      "kind": "source-note",
      "text": "Source: Scorpion Capital consultation calls with experts",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "12fc2df5-1a39-47a0-bc86-95bc2205afb9",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.25,
        "w": 0.86,
        "x": 0.07,
        "y": 0.07
      },
      "kind": "title",
      "text": "Vanderbilt indicated that TransMedics “absolutely” has no value proposition, with an exodus from the device among the top centers and those who participated in its trials",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "27543c85-f61d-4f6c-8e87-592d35937806",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}